Works matching IS 09066705 AND DT 2023 AND VI 32 AND IP 5
Results: 19
Roles of interferon regulatory factor 3 in skin inflammation: Possible involvement of regulatory mechanisms.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 715, doi. 10.1111/exd.14792
- By:
- Publication type:
- Article
Biallelic mutations in LSS in autosomal‐recessive mutilating palmoplantar keratoderma.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Triple Dufourmentel hexagonal flap for scalp reconstruction.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Research letter: A new fluorescent three‐dimensional and deep‐imaging technique for histological identification of individual tumor cells in extramammary Paget's disease.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 712, doi. 10.1111/exd.14759
- By:
- Publication type:
- Article
Role of reflectance confocal microscopy for in vivo investigation of oral disorders: White, red and pigmented lesions.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 648, doi. 10.1111/exd.14758
- By:
- Publication type:
- Article
Sex‐specific differences in oxidative stress markers and collagen expression in perioral skin wrinkling.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 641, doi. 10.1111/exd.14757
- By:
- Publication type:
- Article
Biomodelling and 3D technologies: A novel technique for subungual glomus tumor evaluation.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 710, doi. 10.1111/exd.14756
- By:
- Publication type:
- Article
Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 632, doi. 10.1111/exd.14755
- By:
- Publication type:
- Article
Quantitative morphometric analysis of intrinsic and extrinsic skin ageing in individuals with Fitzpatrick skin types II–III.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 620, doi. 10.1111/exd.14754
- By:
- Publication type:
- Article
Efficacy and safety of topical JAK inhibitors in the treatment of atopic dermatitis in paediatrics and adults: A systematic review.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 599, doi. 10.1111/exd.14753
- By:
- Publication type:
- Article
Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 611, doi. 10.1111/exd.14752
- By:
- Publication type:
- Article
Keratinocytes activated by IL‐4/IL‐13 express IL‐2Rγ with consequences on epidermal barrier function.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 660, doi. 10.1111/exd.14749
- By:
- Publication type:
- Article
The JAK–STAT pathway in keloid pathogenesis: a systematic review with qualitative synthesis.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 588, doi. 10.1111/exd.14747
- By:
- Publication type:
- Article
Concentration‐dependent stimulation of melanin production as well as melanocyte and keratinocyte proliferation by melatonin in human eyelid epidermis.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 684, doi. 10.1111/exd.14740
- By:
- Publication type:
- Article
Melanocortin 1 receptor variants and their association with phenotypic characteristics and sporadic multiple primary melanomas in a cohort of 402 Spanish subjects.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 678, doi. 10.1111/exd.14739
- By:
- Publication type:
- Article
Immune cells and associated molecular markers in dermal fibrosis with focus on raised cutaneous scars.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 570, doi. 10.1111/exd.14734
- By:
- Publication type:
- Article
Persistent alteration of the skin microbiome in patients with skin rash after receiving EGFR inhibitor treatment.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 671, doi. 10.1111/exd.14728
- By:
- Publication type:
- Article
Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapy.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 707, doi. 10.1111/exd.14717
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 567, doi. 10.1111/exd.14592
- Publication type:
- Article